These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37431973)

  • 1. Corticosteroids for the treatment of respiratory infection by Mycoplasma pneumoniae in children: A cost-utility analysis.
    Buendía JA; Patiño DG
    Pediatr Pulmonol; 2023 Oct; 58(10):2809-2814. PubMed ID: 37431973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children.
    Buendía JA; Patiño DG
    Cost Eff Resour Alloc; 2023 Apr; 21(1):23. PubMed ID: 37024913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis.
    Buendía JA; Guerrero Patiño D; Lindarte EF
    BMC Pulm Med; 2022 Jun; 22(1):244. PubMed ID: 35739542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin A supplementation for the prevention of chronic lung disease in premature infants: A cost-utility analysis.
    Buendía JA; Guerrero Patiño D; Lindarte EF
    Pediatr Pulmonol; 2022 Oct; 57(10):2511-2517. PubMed ID: 35794801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis.
    Buendía JA; Patiño DG; Lindarte EF
    BMC Pulm Med; 2022 Dec; 22(1):465. PubMed ID: 36474205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dupilumab in children with moderate-to-severe asthma: A cost utility analysis.
    Buendía JA; Patiño DG
    Pediatr Pulmonol; 2022 Oct; 57(10):2313-2319. PubMed ID: 35668042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand.
    Bamrungsawad N; Upakdee N; Pratoomsoot C; Sruamsiri R; Dilokthornsakul P; Dechanont S; Wu DB; Dejthevaporn C; Chaiyakunapruk N
    Clin Drug Investig; 2016 Jul; 36(7):557-66. PubMed ID: 27113227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cost-Effectiveness of Corticosteroids for the Treatment of Community-Acquired Pneumonia.
    Pliakos EE; Andreatos N; Tansarli GS; Ziakas PD; Mylonakis E
    Chest; 2019 Apr; 155(4):787-794. PubMed ID: 30448195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia.
    Wang K; Gill P; Perera R; Thomson A; Mant D; Harnden A
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD009175. PubMed ID: 23076954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-utility analysis of intravenous immunoglobulin for the treatment of steroid-refractory dermatomyositis in Thailand.
    Bamrungsawad N; Chaiyakunapruk N; Upakdee N; Pratoomsoot C; Sruamsiri R; Dilokthornsakul P
    Pharmacoeconomics; 2015 May; 33(5):521-31. PubMed ID: 25774016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia.
    Antonio Buendía J; Patiño DG
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):575-580. PubMed ID: 34860616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
    Mulholland S; Gavranich JB; Gillies MB; Chang AB
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004875. PubMed ID: 22972079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
    Dai FF; Liu FQ; Chen X; Yang J; Wang K; Guo CY
    J Clin Pharm Ther; 2021 Jun; 46(3):705-710. PubMed ID: 33403672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma.
    Buendía JA; Patiño DG
    BMC Pulm Med; 2021 Dec; 21(1):397. PubMed ID: 34865628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
    Mulholland S; Gavranich JB; Chang AB
    Cochrane Database Syst Rev; 2010 Jul; (7):CD004875. PubMed ID: 20614439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
    Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
    BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children.
    Tsai TA; Tsai CK; Kuo KC; Yu HR
    J Microbiol Immunol Infect; 2021 Aug; 54(4):557-565. PubMed ID: 33268306
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.